Bergenbio Presents Encouraging Updated Preliminary Data From Phase Ii Study In Relapsed Aml Patients At Eha Virtual Meeting ...Middle East

BERGEN, Norway, June 11, 2021 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will present updated preliminary survival data from the ongoing Phase II study of...

Hence then, the article about bergenbio presents encouraging updated preliminary data from phase ii study in relapsed aml patients at eha virtual meeting was published today ( Friday 11/06/2021 - 11:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bergenbio Presents Encouraging Updated Preliminary Data From Phase Ii Study In Relapsed Aml Patients At Eha Virtual Meeting )

Also on site :

• Wardrobe.NYC Brings Its Minimalist Touch to H&M in New Capsule Collection
• Germany and France to take over EU’s largest tank maker
• Legendary ’90s Rocker Announces 2026 Tour Dates After Postponing Shows